For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the association between liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) varies with glycemic status, according to a study published in Hepatology Communications.
from Medical Xpress - latest medical and health news stories https://ift.tt/D3LXx8c
